NTLDKenya

15/10/2025

Kenya has made major strides against TB — a 41% drop in incidence and 65% decline in deaths since 2015. CS launched 80 AI-powered digital X-ray systems & Integrated Lung Health Guidelines, calling for wider TB & lung disease diagnostic access.

The Ministry of Health has recorded progress in the fight against tuberculosis, registering a 41% reduction in TB incidence rate and a 65% drop in TB mortali...

30/09/2025

Day 2 of the symposium featured critical insights on strengthening respiratory care, with a focus on practical implementation and pivotal new national data.

Philip Muchiri from Clinton Health Access Initiative presenting on behalf of Dr.Ibrae Umuro, NTP, underscored the importance of lung health implementation research, highlighting that integrating chronic disease diagnosis into existing primary care platforms is essential for scalable and efficient patient management.

A keynote presentation by Dr. Immaculate Kathure, Ag.Head, NTP, discussed Kenya's latest Drug-Resistant TB (DRTB) Survey.

"The importance of this Drug Resistance Surveillance (DRS) cannot be overstated.It moves the National TB program from operating on assumptions to being guided by precise, evidence-based data."


The survey provides the first robust baseline of Kenya's DRTB burden, which is fundamental for everything from accurate policy-making and strategic planning to rational international resource allocation.

It also reveals a lower-than-expected burden, with a 0.37% prevalence in new patients and 3.35% in retreatment patients. However, Dr. Kathure stressed that this positive news is a call for strategic vigilance, not complacency.

"Continuous monitoring remains essential to safeguard these gains against the persistent threat of new resistance patterns." she said.

29/09/2025

The TB and Lung Health Symposium 2025, convened by Respiratory Society of Kenya(ReSoK) in collaboration with the National Tuberculosis, Leprosy and Lung Disease Program (NTLD-P) & Centre for Health Solutions - Kenya (CHS), is currently underway at the Nairobi Hospital Convention Centre under the theme “Innovation and Integration in Advancing TB and Lung Health.”

Key partners in attendance include the The Ministry of Health, KEMRI, Amref Health Africa in Kenya, Stop TB Partnership Kenya, , Clinton Health Access Initiative CHAI), AstraZeneca, Qure.AI, Glenmark, and other national and international collaborators.

Day One features panel sessions and stakeholder presentations, with discussions centering on the TB burden and its social determinants, sustainable health financing, prevention strategies including vaccines and nutrition and innovations in diagnostics and treatment such as AI-powered X-rays and shorter regimens.

This forum underscores the importance of collective action in bringing together government, researchers, practitioners, industry and advocates to align evidence with practice, strengthen partnerships and drive innovation. It is setting the stage for a stronger, more integrated response to TB and lung health that prioritizes equity and charts a clear path for the future.

Follow the discussions live through: https://www.youtube.com/watch?v=T7kO6j8FYeM


&LungHealthSymposium2025